Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.

Materin, Miguel A; Kuzmik, Gregory A; Jubinsky, Paul T; Minja, Frank J; Asnes, Jeremy D; Bulsara, Ketan R

Materin, Miguel A; Kuzmik, Gregory A; Jubinsky, Paul T; Minja, Frank J; Asnes, Jeremy D; Bulsara, Ketan R.

Affiliation

Materin MA; Department of Ophthalmology and Visual Sciences, Yale School of Medicine, New Haven, Connecticut, USA.

J Neurointerv Surg ; 5(6): e42, 2013 Nov.

Article in En | MEDLINE | ID: mdl-23188789

Subject(s)

Antineoplastic Agents, Alkylating/administration & dosage; Antineoplastic Agents, Alkylating/therapeutic use; Contrast Media; Drug Delivery Systems/methods; Gadolinium; Injections, Intra-Arterial/methods; Melphalan/administration & dosage; Melphalan/therapeutic use; Retinal Artery; Retinal Neoplasms/drug therapy; Retinoblastoma/drug therapy; Cerebral Angiography; Contrast Media/administration & dosage; Follow-Up Studies; Gadolinium/administration & dosage; Humans; Infant; Intraoperative Period; Magnetic Resonance Angiography; Male; Retinal Detachment/surgery; Retinal Neoplasms/pathology; Retinoblastoma/pathology; Treatment Outcome; Visual Acuity

Key words

Angiography; MRI; Neoplasm; Pediatrics; Tumor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Artery / Retinoblastoma / Drug Delivery Systems / Antineoplastic Agents, Alkylating / Contrast Media / Retinal Neoplasms / Gadolinium / Injections, Intra-Arterial / Melphalan Type of study: Observational_studies / Prognostic_studies Limits: Humans / Infant / Male Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google